BridgeBio Pharma, Inc.
BBIO
|
$24.74
-0.84%
-0.85%
2M
|
Health Technology
(0.0% 1d) (-12.9% 1m) (51.5% 1y) (0.0% 2d) (0.0% 3d) (-3.2% 7d) (114.03% volume)
Earnings Calendar: 2024-02-22
Market Cap: $ 4,350,072,201
http://www.bridgebio.com
Sec Filling | Patents | 248 employees
(US) BridgeBio Pharma, Inc. is a pharma company. The firm engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly and Neil Kumar on May 17, 2019 and is headquartered in Palo Alto, CA.
cancer genetic
add to watch list Paper trade email alert is off
Press-releases
Sentynl Therapeutics Receives MHRA Authorization of NULIBRY® (fosdenopterin) for Treatment of MoCD Type A in Great Britain
Published: 2024-04-16 (Crawled : 16:00) - biospace.com/
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: -1.47%
H: 2.05%
C: -0.59%
nulibry authorization treatment for therapeutics
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-10 (Crawled : 12:00) - bridgebio.com
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: -4.11%
H: 0.81%
C: 0.15%
pharma nasdaq grants
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 10, 2024
Published: 2024-04-10 (Crawled : 12:00) - biospace.com/
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: -4.11%
H: 0.81%
C: 0.15%
pharma nasdaq grants
BridgeBio Pharma Presents Cardiac Magnetic Resonance (CMR) Imaging Evidence Consistent with Clinical Improvement Observed in the ATTRibute-CM Phase 3 Study in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Published: 2024-04-07 (Crawled : 20:20) - bridgebio.com
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
| Email alert
Add to watchlist
pharma cardiac imaging study
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-20 (Crawled : 12:00) - bridgebio.com
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 0.46%
H: 1.37%
C: 0.25%
pharma nasdaq grants
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - March 20, 2024
Published: 2024-03-20 (Crawled : 12:00) - biospace.com/
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 0.46%
H: 1.37%
C: 0.25%
pharma nasdaq grants
BridgeBio Pharma Announces Pricing of Public Offering of Common Stock
Published: 2024-03-06 (Crawled : 05:00) - bridgebio.com
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 2.36%
H: 2.34%
C: -2.81%
pharma offering
BridgeBio Pharma Announces Pricing of Public Offering of Common Stock - March 06, 2024
Published: 2024-03-06 (Crawled : 12:00) - biospace.com/
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 2.36%
H: 2.34%
C: -2.81%
pharma offering
Invitae to Present Data at the 2024 ACMG Annual Clinical Genetics Meeting
Published: 2024-03-05 (Crawled : 12:30) - prnewswire.com
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: -2.32%
H: 0.62%
C: -6.34%
meeting
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
Published: 2024-03-04 (Crawled : 21:00) - globenewswire.com
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: -2.32%
H: 0.62%
C: -6.34%
pharma offering
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10